CompuGroup Medical SE & Co. KGaA Cash Flow Quality Index
CompuGroup Medical SE & Co. KGaA cash flow quality index. CompuGroup Medical SE & Co. KGaA (COP) has a Cash Flow Quality Index of 8.50x as of March 2025. Operating cash flow of €93.91 Million exceeds net income of €11.05 Million, indicating high earnings quality where cash backs reported profits. See COP free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of CompuGroup Medical SE & Co. KGaA (2004–2024)
Cash flow quality index of CompuGroup Medical SE & Co. KGaA from 2004 to 2024. Historical Cash Flow Quality Index for CompuGroup Medical SE & Co. KGaA across 21 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CompuGroup Medical SE & Co. KGaA cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
CompuGroup Medical SE & Co. KGaA Cash Flow Quality Index by Year (2004–2024)
CompuGroup Medical SE & Co. KGaA cash flow quality index by year from 2004 to 2024. Year-by-year earnings quality comparison for CompuGroup Medical SE & Co. KGaA. For the full cash flow conversion analysis, see CompuGroup Medical SE & Co. KGaA (COP) cash conversion ratio.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 3.71x | €128.88 Million | €34.76 Million | ▼ -3.2% |
| 2023 | 3.83x | €179.53 Million | €46.87 Million | ▲ +95.7% |
| 2022 | 1.96x | €145.03 Million | €74.12 Million | ▼ -18.3% |
| 2021 | 2.39x | €165.27 Million | €69.03 Million | ▲ +17.2% |
| 2020 | 2.04x | €149.93 Million | €73.42 Million | ▲ +22.3% |
| 2019 | 1.67x | €110.50 Million | €66.15 Million | ▲ +18.0% |
| 2018 | 1.42x | €136.35 Million | €96.34 Million | ▼ -47.8% |
| 2017 | 2.71x | €85.82 Million | €31.68 Million | ▲ +78.4% |
| 2016 | 1.52x | €67.61 Million | €44.53 Million | ▼ -19.9% |
| 2015 | 1.90x | €73.25 Million | €38.62 Million | ▲ +43.1% |
| 2014 | 1.33x | €31.94 Million | €24.10 Million | ▼ -45.0% |
| 2013 | 2.41x | €52.33 Million | €21.72 Million | ▲ +9.6% |
| 2012 | 2.20x | €66.91 Million | €30.42 Million | ▼ -54.1% |
| 2011 | 4.79x | €46.74 Million | €9.75 Million | ▲ +95.1% |
| 2010 | 2.46x | €40.38 Million | €16.43 Million | ▼ -34.6% |
| 2009 | 3.76x | €44.00 Million | €11.72 Million | ▼ -81.6% |
| 2008 | 20.44x | €25.91 Million | €1.27 Million | ▲ +1768.4% |
| 2007 | 1.09x | €25.19 Million | €23.03 Million | ▼ -61.3% |
| 2006 | 2.82x | €16.50 Million | €5.84 Million | ▲ +80.2% |
| 2005 | 1.57x | €24.06 Million | €15.35 Million | ▼ -31.4% |
| 2004 | 2.28x | €22.51 Million | €9.86 Million | — |